Related Experiment Video
Updated: Jun 18, 2026
14:48
Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
5.1K
Immune Signatures of SARS-CoV-2 Infection Resolution in Human Lung Tissues
Devin Kenney1,2, Aoife K O'Connell1,2,3, Anna E Tseng1,2,3
1Department of Virology, Immunology, and Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Biorxiv : the Preprint Server for Biology
|March 18, 2024
Summary
This study reveals key immune responses in human lung tissues that resolve SARS-CoV-2 infection. Specific immune cells like CD4+ T-cells are crucial for clearing the virus and preventing persistent infection.
Area of Science:
- Immunology
- Respiratory Medicine
- Virology
Background:
- Human autopsy data offer limited insight into favorable viral respiratory infection resolution.
- Understanding mechanisms of viral clearance is crucial for treating diseases like COVID-19.
Purpose of the Study:
- To map immunological events during SARS-CoV-2 infection resolution in human lung tissues.
- To identify immune cell subsets critical for viral clearance and favorable outcomes.
Main Methods:
- Utilized a humanized mouse model with human immune system and fetal lung xenografts (fLX).
- Analyzed immunological and histopathological changes in fLX following SARS-CoV-2 infection.
- Investigated the role of specific immune cell populations, including CD4+ T-cells, in infection resolution.
Main Results:
- Rapid viral clearance from fLX after initial replication, mirroring human COVID-19 pathology.
- Infection resolution linked to activated inflammatory monocytes and cytotoxic double-negative T-cells.
- Human CD4+ T-cell depletion impaired viral clearance, leading to persistent infection, while CD3+ cell depletion did not.
Conclusions:
- Identified critical immune mechanisms driving effective SARS-CoV-2 resolution in human lung tissue.
- Highlighted the essential role of CD4+ T-cells in clearing SARS-CoV-2 and achieving favorable clinical outcomes.
- Demonstrated distinct immunological pathways in resolving versus fatal COVID-19 cases.
Related Concept Videos
01:26Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
01:29Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...